sunitinib (Q417542)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

chemical compound

SU11248
SU-11248

Language	Label	Description	Also known as
English	sunitinib	chemical compound	SU11248 SU-11248

Statements

type of chemical entity

0 references

heterocyclic compound

0 references

0 references

chemical structure

Sunitinib.svg
818 × 542; 3 KB

0 references

image of molecular model or crystal lattice model

Sunitinib-3D-balls.png
1,100 × 987; 195 KB

ball-and-stick model

0 references

398.212 dalton

1 reference

language of work or name

Sunitinib (English)

19 October 2016

chemical formula

C₂₂H₂₇FN₄O₂

1 reference

language of work or name

Sunitinib (English)

19 November 2016

canonical SMILES

CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C

1 reference

language of work or name

Sunitinib (English)

19 November 2016

isomeric SMILES

CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C

1 reference

language of work or name

Sunitinib (English)

19 November 2016

active ingredient in

1 reference

14 February 2018

World Health Organisation international non-proprietary name

sunitinib (English)

1 reference

language of work or name

Sunitinib (English)

19 January 2016

Penicillium terrestre

reason for deprecated rank

cannot be confirmed by other sources

1 reference

Gentisyl alcohol derivatives from the marine-derived fungus Penicillium terrestre

Penicillium solitum

1 reference

Gentisyl alcohol derivatives from the marine-derived fungus Penicillium terrestre

medical condition treated

neuroendocrine carcinoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

renal clear cell carcinoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

rare urinary tract tumor

1 reference

Drug Indications Extracted from FAERS

2 October 2018

gastrointestinal stromal tumor

1 reference

Drug Indications Extracted from FAERS

2 October 2018

carcinoid tumor

1 reference

Drug Indications Extracted from FAERS

2 October 2018

renal cell carcinoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

gastrointestinal carcinoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

renal pelvis carcinoma

1 reference

Drug Indications Extracted from FAERS

2 October 2018

1 reference

Drug Indications Extracted from FAERS

2 October 2018

connective tissue neoplasm

1 reference

Drug Indications Extracted from FAERS

2 October 2018

1 reference

Drug Indications Extracted from FAERS

2 October 2018

pancreatic cancer

26 January 2006

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/V99T50803M

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021938s031lbl.pdf

renal cell carcinoma

26 January 2006

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/V99T50803M

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021938s031lbl.pdf

gastrointestinal stromal tumor

26 January 2006

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/V99T50803M

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021938s031lbl.pdf

significant drug interaction

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

bone marrow failure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

bone marrow failure

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Fibroblast growth factor receptor 1

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

fms related receptor tyrosine kinase 3

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

Fms related receptor tyrosine kinase 4

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

Kinase insert domain receptor

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

KIT proto-oncogene, receptor tyrosine kinase

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

Platelet derived growth factor receptor beta

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

ret proto-oncogene

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

pregnancy category

Australian pregnancy category D

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category D

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category B

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Sunitinib

27 June 2018

subject has role

protein kinase inhibitors

1 reference

5 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

angiogenesis inhibitor

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

SUNItinib

has characteristic

Tall Man lettering

Institute for Safe Medication Practices

1 reference

https://www.ismp.org/recommendations/tall-man-letters-list

2 September 2022

0 references

0 references

0 references

Commons category

Sunitinib

0 references

Identifiers

InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-

1 reference

language of work or name

Sunitinib (English)

19 November 2016

WINHZLLDWRZWRT-ATVHPVEESA-N

2 references

language of work or name

Sunitinib (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

2 references

Global Substance Registration System

language of work or name

sunitinib (English)

19 November 2016

WINHZLLDWRZWRT-ATVHPVEESA-N

CAS Common Chemistry

9 April 2021

https://commonchemistry.cas.org/detail?cas_rn=557795-19-4

1 reference

language of work or name

Sunitinib (English)

19 November 2016

2 references

language of work or name

Sunitinib (English)

19 November 2016

matched by identifier from

WINHZLLDWRZWRT-ATVHPVEESA-N

mapping relation type

2 references

language of work or name

SUNITINIB (English)

19 November 2016

matched by identifier from

International Chemical Identifier

InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-

1 reference

language of work or name

SUNITINIB (English)

19 November 2016

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

WINHZLLDWRZWRT-ATVHPVEESA-N

UniChem compound ID

1 reference

1 reference

Hazardous Substances Data Bank

publication date

28 October 2019

Sunitinib (English)

10 May 2021

DSSTox substance ID

0 references

DSSTOX compound identifier

0 references

0 references

0 references

0 references

1 reference

language of work or name

Sunitinib (English)

publication date

17 November 2015

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

sunitinib (English)

19 November 2016

MeSH descriptor ID

subject named as

Sunitinib

0 references

D03.383.129.578.823

0 references

D03.633.100.473.877

0 references

1 reference

Global Substance Registration System

language of work or name

sunitinib (English)

19 November 2016

1 reference

matched by identifier from

WINHZLLDWRZWRT-ATVHPVEESA-N

Human Metabolome Database ID

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

WINHZLLDWRZWRT-ATVHPVEESA-N

2 references

Global Substance Registration System

language of work or name

sunitinib (English)

19 November 2016

matched by identifier from

WINHZLLDWRZWRT-ATVHPVEESA-N

MedlinePlus drug identifier

0 references

PatientsLikeMe treatment ID

0 references

1 reference

Global Substance Registration System

language of work or name

sunitinib (English)

19 November 2016

Probes And Drugs ID

0 references

1 reference

1 reference

language of work or name

Sunitinib (English)

19 January 2016

0 references

0 references

1 reference

Freebase Data Dumps

publication date

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

PDB structure ID

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4KS8 (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3G0F (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3G0E (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3MIY (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

2Y7J (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

3TI1 (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4QMZ (English)

19 October 2016

1 reference

Protein Data Bank

PDB structure ID

language of work or name

4AGD (English)

19 October 2016

UK Parliament thesaurus ID

subject named as

Sunitinib

0 references

1 reference

Global Substance Registration System

language of work or name

sunitinib (English)

19 November 2016

1 reference

based on heuristic

inferred by common MeSH mappings on source and on Wikidata

25 May 2023

WikiProjectMed ID

0 references

Sitelinks

Wikipedia(18 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

commonswiki Category:Sunitinib

Retrieved from "https://www.wikidata.org/w/index.php?title=Q417542&oldid=2186660156"